Target intelligence / Profile preview

Dietary substrates (Lipids, Proteins, and Carbohydrates)

Molecular classification
Other
01

Overview

The target refers to the collective group of dietary macronutrients—lipids, proteins, and carbohydrates—present within the gastrointestinal lumen that require enzymatic breakdown for systemic absorption. In patients suffering from Exocrine Pancreatic Insufficiency (EPI), the pancreas fails to secrete adequate amounts of endogenous digestive enzymes, leading to significant malabsorption and malnutrition [Mayo Clinic, 2023]. Pancreatic Enzyme Replacement Therapy (PERT) addresses this by providing exogenous lipase, protease, and amylase that directly target these luminal substrates [StatPearls, 2023]. Lipase facilitates the hydrolysis of fats into monoglycerides and free fatty acids, while proteases and amylases break down proteins and complex starches into absorbable peptides and simple sugars, respectively [PubChem, 2024]. This therapeutic intervention is critical for managing conditions such as cystic fibrosis, chronic pancreatitis, and pancreatic cancer, as it restores digestive function and improves the patient's nutritional status [Cystic Fibrosis Foundation, 2023]. Effective management requires precise dosing based on the fat content of the substrates to prevent symptoms like steatorrhea and weight loss.

Other names
Luminal dietary substratesMacronutrientsDietary fats, proteins, and starchesPancreatic enzyme substrates
02

Mechanism of action

Exogenous pancreatic enzymes (lipase, protease, and amylase) act within the gastrointestinal lumen to catalyze the hydrolysis of dietary fats into fatty acids and glycerol, proteins into peptides and amino acids, and carbohydrates into simple sugars, thereby facilitating their absorption [StatPearls, 2023; PubChem, 2024].

03

Biological functions

DigestionNutrient absorptionMacronutrient metabolism
04

Disease associations

Exocrine pancreatic insufficiencyCystic fibrosisChronic pancreatitisPancreatic cancerShwachman-Diamond syndrome
05

Safety considerations

Fibrosing colonopathy (associated with high doses in cystic fibrosis patients)HyperuricosuriaHyperuricemiaAllergic reactions to porcine-derived productsOral mucosal irritation [StatPearls, 2023; Cystic Fibrosis Foundation, 2023]
06

Interacting drugs

Pancrelipase (Creon, Zenpep, Pancreaze, Pertzye, Viokace)

1 more in the full profile.

07

Biomarkers

Fecal elastase-1Coefficient of fat absorption (CFA)13C-mixed triglyceride breath testFecal fat excretion [Mayo Clinic, 2023]

Beyond the preview

Go deeper on Dietary substrates (Lipids, Proteins, and Carbohydrates).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary substrates (Lipids, Proteins, and Carbohydrates).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call